Stakeholders in Bangladesh convened in Dhaka to call for the rapid scale-up of shorter, injection-free DR-TB regimens such as BPaL/M, highlighting their potential to dramatically improve patient outcomes and accelerate progress toward ending DR-TB. The consultation underscored the importance of coordinated policy action, sustainable supply, and strong community engagement to ensure these modern treatments reach all who need them, particularly in urban and underserved communities.

Bangladesh has taken a powerful step forward in the fight against drug-resistant tuberculosis (DR-TB). The country’s National Tuberculosis Program (NTP), under the Ministry of Health and Family Welfare (MoHFW), has officially begun the national rollout of the six-month, all-oral BPaL/BPaLM regimen.

The PeerLINC Knowledge Hub hosted a weeklong capacity-building program for Bangladesh’s National Tuberculosis Program (NTP) managers to equip national leaders with the tools and knowledge to speed up the rollout of six-month BPaLM/BPaL regimens. Among the attendees was Dr. Khaled Bin Yousef, Director of Programmes at FTTC implementing partner, Nari Maitree.